J1322 Injection, elosulfase alfa, 1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Elosulfase alfa, injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, elosulfase alfa, 1 mg | yes |
Related codes in J13
- J1301 Injection, edaravone, 1 mg
- J1302 Injection, sutimlimab-jome, 10 mg
- J1303 Injection, ravulizumab-cwvz, 10 mg
- J1304 Injection, tofersen, 1 mg
- J1305 Injection, evinacumab-dgnb, 5mg
- J1306 Injection, inclisiran, 1 mg
- J1307 Injection, crovalimab-akkz, 10 mg
- J1308 Injection, famotidine, 0.25 mg
- J1320 Injection, amitriptyline hcl, up to 20 mg
- J1323 Injection, elranatamab-bcmm, 1 mg
- J1324 Injection, enfuvirtide, 1 mg
- J1325 Injection, epoprostenol, 0.5 mg
- J1326 Injection, zolbetuximab-clzb, 2 mg
- J1327 Injection, eptifibatide, 5 mg
- J1335 Injection, ertapenem sodium, 500 mg
- J1364 Injection, erythromycin lactobionate, per 500 mg
- J1370 Injection, esomeprazole sodium, 1 mg
- J1380 Injection, estradiol valerate, up to 10 mg